AZD‐9668

Executive summary

The term chronic obstructive pulmonary disease (COPD) covers a complex group of disorders characterized by a progressive development of airflow limitation. Key risk factors of the disease are cigarette smoke and air pollution. In addition, a genetic component is involved in the development  of COPD. It is set to become the third leading cause of death in the developed world by 2020.
AZD‐9668 is a protease (lactase) inhibitor.

 

 

Table of content

I. Presentation - General Information

II. Chronic Obstructive Pulmonary
Disease 
Market Analysis
Treatment
Trends 
New Treatments for COPD 

III. Originator

IV. Clinical Trials

V. SWOT

VI. News

 

 

Publication date: Number of pages: Price:
2010-04-01 14 1500 euros